IBDEI37Z ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,54115,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,54115,1,1,0)
 ;;=1^36556
 ;;^UTILITY(U,$J,358.3,54115,1,2,0)
 ;;=2^INSERT CENTRAL LINE
 ;;^UTILITY(U,$J,358.3,54116,0)
 ;;=31500^^255^2758^2^^^^1
 ;;^UTILITY(U,$J,358.3,54116,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,54116,1,1,0)
 ;;=1^31500
 ;;^UTILITY(U,$J,358.3,54116,1,2,0)
 ;;=2^INTUBATION
 ;;^UTILITY(U,$J,358.3,54117,0)
 ;;=B18.2^^256^2759^26
 ;;^UTILITY(U,$J,358.3,54117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54117,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,54117,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,54117,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,54118,0)
 ;;=C44.99^^256^2759^50
 ;;^UTILITY(U,$J,358.3,54118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54118,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,54118,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,54118,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,54119,0)
 ;;=E11.9^^256^2759^15
 ;;^UTILITY(U,$J,358.3,54119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54119,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,54119,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,54119,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,54120,0)
 ;;=E11.40^^256^2759^16
 ;;^UTILITY(U,$J,358.3,54120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54120,1,3,0)
 ;;=3^Diabetes Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,54120,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,54120,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,54121,0)
 ;;=E78.2^^256^2759^27
 ;;^UTILITY(U,$J,358.3,54121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54121,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,54121,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,54121,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,54122,0)
 ;;=E78.5^^256^2759^28
 ;;^UTILITY(U,$J,358.3,54122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54122,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,54122,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,54122,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,54123,0)
 ;;=E66.3^^256^2759^44
 ;;^UTILITY(U,$J,358.3,54123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54123,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,54123,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,54123,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,54124,0)
 ;;=D64.9^^256^2759^3
 ;;^UTILITY(U,$J,358.3,54124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54124,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,54124,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,54124,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,54125,0)
 ;;=F17.200^^256^2759^41
 ;;^UTILITY(U,$J,358.3,54125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54125,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,54125,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,54125,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,54126,0)
 ;;=F17.229^^256^2759^38
 ;;^UTILITY(U,$J,358.3,54126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54126,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,54126,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,54126,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,54127,0)
 ;;=F19.10^^256^2759^53
 ;;^UTILITY(U,$J,358.3,54127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54127,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,54127,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,54127,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,54128,0)
 ;;=F15.10^^256^2759^52
 ;;^UTILITY(U,$J,358.3,54128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54128,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,54128,1,4,0)
 ;;=4^F15.10
 ;;^UTILITY(U,$J,358.3,54128,2)
 ;;=^5003282
 ;;^UTILITY(U,$J,358.3,54129,0)
 ;;=F43.21^^256^2759^2
